|
[1]Hoshida Y, Toffanin S, Lachenmayer A, et al.Molecularclassification and novel targets in hepatocellular carcinoma:recentadvancements[J].Semin Liver Dis, 2010, 30 (1) :35-51.
|
|
[2]Stefaniuk P, Cianciara J, Wiercinska-Drapalo A.Present and futurepossibilities for early diagnosis of hepatocellular carcinoma[J].World J Gastroenterol, 2010, 16 (4) :418-424.
|
|
[3]Sun Q, Zhang Y, Liu F, et al.Identification of candidate biomarkersfor hepatocellular carcinoma through pre-cancerous expressionanalysis in an HBx transgenic mouse[J].Cancer Biol Ther, 2007, 6 (10) :1532-1538.
|
|
[4]Gerke V, Moss SE.Annexins:from structure to function[J].PhysiolRev, 2002, 82 (2) :331-371.
|
|
[5]Rescher U, Gerke V.S100A10/p11:family, friends and functions[J].Pflugers Arch, 2008, 455 (4) :575-582.
|
|
[6]Mohammad HS, Kurokohchi K, Yoneyama H, et al.Annexin A2expression and phosphorylation are up-regulated in hepatocellularcarcinoma[J].Int J Oncol, 2008, 33 (6) :1157-1163.
|
|
[7]He KL, Deora AB, Xiong H, et al.Endothelial cell annexin A2regulates polyubiquitination and degradation of its binding partnerS100A10/p11[J].J Biol Chem, 2008, 283 (28) :19192-19200.
|
|
[8]Dassah M, Deora AB, He K, et al.The endothelial cell annexin A2system and vascular fibrinolysis[J].Gen Physiol Biophys, 2009, 28:F20-28.
|
|
[9]Li Q, Ke F, Zhang W, et al.A role for the annexin A2 amino-terminal peptide in the plasmin-induced activation of humanperipheral monocytes[J].Mol Immunol, 2010, 47 (14) :2405-2410.
|
|
[10]Luo W, Yan G, Li L, et al.Epstein-Barr virus latent membraneprotein 1 mediates serine 25 phosphorylation and nuclear entryof annexin A2 via PI-PLC-PKCalpha/PKCbeta pathway[J].MolCarcinog, 2008, 47 (12) :934-946.
|
|
[11]Gao PJ, Shi Y, Gao YH, et al.The receptor for beta (2) GP I onmembrane of hepatocellular carcinoma cell line SMMC-7721 isannexin II[J].World J Gastroenterol, 2007, 13 (24) :3364-3368.
|
|
[12]Huang Y, Jin Y, Yan CH, et al.Involvement of Annexin A2 in p53induced apoptosis in lung cancer[J].Mol Cell Biochem, 2008, 309 (1-2) :117-123.
|
|
[13]Kapoor M, Zhou Q, Otero F, et al.Evidence for annexin II-S100A10 complex and plasmin in mobilization of cytokine activityof human TrpRS[J].J Biol Chem, 2008, 283 (4) :2070-2077.
|
|
[14]Kesavan K, Ratliff J, Johnson EW, et al.Annexin A2 is a moleculartarget for TM601, a peptide with tumor-targeting and anti-angiogenic effects[J].J Biol Chem, 2010, 285 (7) :4366-4374.
|
|
[15]Su SC, Maxwell SA, Bayless KJ.Annexin 2 regulates endothelialmorphogenesis by controlling AKT activation and junctionalintegrity[J].J Biol Chem, 2010, 285 (52) :40624-40634.
|
|
[16]Bao H, Jiang M, Zhu M, et al.Overexpression of Annexin IIaffects the proliferation, apoptosis, invasion and production ofproangiogenic factors in multiple myeloma[J].Int J Hematol, 2009, 90 (2) :177-185.
|
|
[17]Dai Z, Zhou J, Li XF, et al.An analysis of annexin II related to HCCmetastatic ability[J].Chin J Hepatol, 2007, 15 (8) :563-566.
|
|
[18]Yu GR, Kim SH, Park SH, et al.Identification of molecular markersfor the oncogenic differentiation of hepatocellular carcinoma[J].Exp Mol Med, 2007, 39 (5) :641-652.
|
|
[19]Longerich T, Haller MT, Mogler C, et al.Annexin A2 as a differentialdiagnostic marker of hepatocellular tumors[J].Pathol Res Pract, 2011, 207 (1) :8-14.
|
|
[20]Ji NY, Park MY, Kang YH, et al.Evaluation of annexin II as apotential serum marker for hepatocellular carcinoma using adeveloped sandwich ELISA method[J].Int J Mol Med, 2009, 24 (6) :765-771.
|
|
[21]Zhao P, Zhang W, Tang J, et al.Annexin II promotes invasion andmigration of human hepatocellular carcinoma cells in vitro via itsinteraction with HAb18G/CD147[J].Cancer Sci, 2010, 101 (2) :387-395.
|
|
[22]Zhang F, Zhang L, Zhang B, et al.Anxa2 plays a critical role inenhanced invasiveness of the multidrug resistant human breastcancer cells[J].J Proteome Res, 2009, 8 (11) :5041-5047.
|
|
[23] Kwaan HC, McMahon B.The role of plasminogen-plasmin systemin cancer[J].Cancer Treat Res, 2009, 148:43-66.
|
|
[24]O'Connell PA, Surette AP, Liwski RS, et al.S100A10 regulatesplasminogen-dependent macrophage invasion[J].Blood, 2010, 116 (7) :1136-1146.
|
|
[25]Marrero JA, Kudo M, Bronowicki JP.The challenge of prognosisand staging for hepatocellular carcinoma[J].Oncologist, 2010, 15 (Suppl 4) :23-33.
|
|
[26]Dong ZZ, Yao DF, Wu W, et al.Delayed hepatocarcinogenesisthrough antiangiogenic intervention in the nuclear factor-kappa Bactivation pathway in rats[J].Hepatobiliary Pancreat Dis Int, 2010, 9 (2) :169-174.
|
|
[27]Qian J, Yao D, Dong Z, et al.Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA inmetastasis of hepatocellular carcinoma[J].Am J Clin Pathol, 2010, 134 (5) :799-806.
|
|
[28]Hofmann A, Osman A, Leow CY, et al.Parasite annexins--newmolecules with potential for drug and vaccine development[J].Bioessays, 2010, 32 (11) :967-976.
|
DownLoad: